D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 72 Citations 14,906 335 World Ranking 14058 National Ranking 517

Research.com Recognitions

Awards & Achievements

2015 - Fellow of the Australian Academy of Health and Medical Science

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Gene
  • Disease

The scientist’s investigation covers issues in Macular degeneration, Visual acuity, Ophthalmology, Internal medicine and Surgery. Her Macular degeneration research is mostly focused on the topic Choroidal neovascularization. Robyn H. Guymer has researched Visual acuity in several fields, including Adverse effect, Left eye, Randomized controlled trial and Age related.

The concepts of her Ophthalmology study are interwoven with issues in Retina and Maculopathy. Her research integrates issues of Dietary fat, Clinical trial, Environmental health and Risk factor in her study of Surgery. Robyn H. Guymer works mostly in the field of Drusen, limiting it down to concerns involving Pathology and, occasionally, Retinal and Macular telangiectasia.

Her most cited work include:

  • A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants (638 citations)
  • Seven new loci associated with age-related macular degeneration (584 citations)
  • A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. (365 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Macular degeneration, Ophthalmology, Age related, Visual acuity and Internal medicine. Her Macular degeneration study incorporates themes from Prospective cohort study and Surgery. Her study in Ophthalmology is interdisciplinary in nature, drawing from both Maculopathy and Atrophy.

Her work on Geographic atrophy as part of general Age related study is frequently linked to In patient, bridging the gap between disciplines. Her research in Visual acuity intersects with topics in Optometry and Randomized controlled trial. Her Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Oncology.

She most often published in these fields:

  • Macular degeneration (62.74%)
  • Ophthalmology (45.17%)
  • Age related (28.96%)

What were the highlights of her more recent work (between 2017-2021)?

  • Macular degeneration (62.74%)
  • Ophthalmology (45.17%)
  • Age related (28.96%)

In recent papers she was focusing on the following fields of study:

Robyn H. Guymer mostly deals with Macular degeneration, Ophthalmology, Age related, Visual acuity and Drusen. Her work on Choroidal neovascularization as part of general Macular degeneration research is often related to Ranibizumab, thus linking different fields of science. Many of her research projects under Ranibizumab are closely connected to Pediatrics, Cohort and Retrospective cohort study with Pediatrics, Cohort and Retrospective cohort study, tying the diverse disciplines of science together.

Her work on Reticular pseudodrusen is typically connected to Subthreshold conduction, In patient and Multimodal imaging as part of general Age related study, connecting several disciplines of science. Her Visual acuity research incorporates themes from Night vision, Luminance, Optometry, Randomized controlled trial and Prospective cohort study. Her research investigates the link between Drusen and topics such as Fundus that cross with problems in Maculopathy.

Between 2017 and 2021, her most popular works were:

  • Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group (68 citations)
  • Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial (64 citations)
  • Tolerating subretinal fluid in neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend regimen: FLUID study 24-month results (63 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

Robyn H. Guymer focuses on Macular degeneration, Visual acuity, Ophthalmology, Retinal and Drusen. In her works, Robyn H. Guymer undertakes multidisciplinary study on Macular degeneration and Ranibizumab. Her Visual acuity research integrates issues from Clinical trial, MEDLINE, Regimen, Randomized controlled trial and Age related.

Her Ophthalmology research incorporates elements of Lesion, Prospective cohort study and Functional recovery. Her work in the fields of Retinal, such as Retinal pigment epithelium, Microperimetry and Reticular pseudodrusen, overlaps with other areas such as Recovery rate and Test point. Her Drusen research is multidisciplinary, incorporating perspectives in Optical coherence tomography, Activities of daily living, Confounding and Confidence interval.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Seven new loci associated with age-related macular degeneration

Lars G. Fritsche;Lars G. Fritsche;Wei Chen;Wei Chen;Matthew Schu;Brian L. Yaspan.
Nature Genetics (2013)

656 Citations

A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants

Lars G. Fritsche;Wilmar Igl;Jessica N.Cooke Bailey;Felix Grassmann.
Nature Genetics (2016)

614 Citations

A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.

Edwin M. Stone;Andrew J. Lotery;Francis L. Munier;Elise Héon.
Nature Genetics (1999)

449 Citations

Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study.

Ursula Schmidt-Erfurth;Bora Eldem;Robyn Guymer;Jean-François Korobelnik.
Ophthalmology (2011)

436 Citations

Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study.

Frank G. Holz;Winfried Amoaku;Juan Donate;Robyn H. Guymer.
Ophthalmology (2011)

434 Citations

Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis.

Elaine W-T Chong;Andréas Josef Kreis;Tien Y Wong;Julie A Simpson.
Archives of Ophthalmology (2008)

319 Citations

Automatic segmentation of nine retinal layer boundaries in OCT images of non-exudative AMD patients using deep learning and graph search.

Leyuan Fang;David Cunefare;Chong Wang;Robyn H. Guymer.
Biomedical Optics Express (2017)

297 Citations

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration

Yi Yu;Tushar R. Bhangale;Jesen Fagerness;Jesen Fagerness;Stephan Ripke;Stephan Ripke.
Human Molecular Genetics (2011)

259 Citations

The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration.

Paul N Baird;Elizabeth Guida;Diep T Chu;Hien T V Vu.
Investigative Ophthalmology & Visual Science (2004)

257 Citations

Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis

Elaine W-T Chong;Tien Y Wong;Andréas Josef Kreis;Julie A Simpson.
BMJ (2007)

256 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robyn H. Guymer

Frank G. Holz

Frank G. Holz

University of Bonn

Publications: 115

Tien Yin Wong

Tien Yin Wong

National University of Singapore

Publications: 115

Emily Y. Chew

Emily Y. Chew

National Institutes of Health

Publications: 112

Anneke I. den Hollander

Anneke I. den Hollander

Radboud University Nijmegen

Publications: 83

Paul Mitchell

Paul Mitchell

University of Sydney

Publications: 80

Srinivas R. Sadda

Srinivas R. Sadda

University of California, Los Angeles

Publications: 79

Christine A. Curcio

Christine A. Curcio

University of Alabama at Birmingham

Publications: 76

Caroline C W Klaver

Caroline C W Klaver

Erasmus University Rotterdam

Publications: 76

Usha Chakravarthy

Usha Chakravarthy

Queen's University Belfast

Publications: 70

Bernhard H. F. Weber

Bernhard H. F. Weber

University of Regensburg

Publications: 69

Carel B. Hoyng

Carel B. Hoyng

Radboud University Nijmegen

Publications: 68

Johanna M. Seddon

Johanna M. Seddon

University of Massachusetts Medical School

Publications: 66

Ursula Schmidt-Erfurth

Ursula Schmidt-Erfurth

Medical University of Vienna

Publications: 62

K. Bailey Freund

K. Bailey Freund

New York University

Publications: 61

Anand Swaroop

Anand Swaroop

National Institutes of Health

Publications: 58

Jie Jin Wang

Jie Jin Wang

University of Sydney

Publications: 53

Something went wrong. Please try again later.